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Abstract
High-throughput sequencing technology allows researchers to test associations between phenotypes and all the
variants identified throughout the genome, and is especially useful for analyzing rare variants. However, the
statistical power to identify phenotype-associated rare variants is very low with typical genome-wide association
studies because of their low allele frequencies among unrelated individuals. In contrast, a family-based design may
have more power because rare variants are more likely to be enriched in families than among unrelated
individuals. Regardless, an analysis of family-based association studies needs to account appropriately for
relatedness between family members. We analyzed the observed quantitative trait systolic blood pressure as well
as the simulated Q1 data in the Genetic Analysis Workshop 18 data set using 4 tests: (a) a single-variant test, (b) a
collapsing test, (c) a single-variant test where familial relatedness was accounted for, and (d) a collapsing test
where familial relatedness was accounted for. We then compared the results of the 4 methods and observed that
adjusting for familial relatedness could appropriately control the false-positive rate while maintaining reasonable
power to detect several strongly associated variants/genes.
Background
Current platforms for genome-wide association studies are
limited to scanning common variants. Although rare var-
iants may contribute a significant proportion of heritabil-
ity, the statistical power to detect rare variants is low
because of their low allele frequencies. Recent advances in
high-throughput sequencing technologies have provided
us great opportunities to delve deeper into the genetic
components of complex traits by identifying millions of
rare variants in the human genome [1] and allowing them
to be tested for associations with complex traits.
In an effort to increase the power to detect rare-variant
associations, many methods have been proposed to aggre-
gate the effects of multiple rare variants within a specific
functional unit, for example, a gene [2]. Among those
methods, the kernel score test has enjoyed great popularity
thanks to its flexibility and computational efficiency [3].
Family-based designs may offer more power, however,
because related individuals are more likely than unrelated
individuals to be enriched for rare variants [4]. One chal-
lenge of analyzing family data is that familial relatedness
needs to be carefully adjusted for in the association analy-
sis. Linear mixed models have been used to account for
population stratification in the context of genome-wide
association studies (GWAS) [5], and can also be naturally
adapted to a family-based design. In this paper, we
adopted a linear mixed model to adjust for familial relat-
edness while aggregating the effects of rare variants within
a gene using a kernel score test.
Methods
Data description and preprocessing
The Genetic Analysis Workshop 18 (GAW18) data con-
sists of genotyping and sequencing data for 959 individuals
from 20 extended families. Among them, 849 individuals
had at least 1 blood pressure measurement. For the real
data, we used the first nonmissing measurement of systolic
blood pressure (SBP) as the target quantitative trait. For
the 200 replicates of the simulated phenotype, we also used
the first measurement of SBP as the target quantitative
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trait. Finally, to evaluate the false-positive rate, we used the
simulated Q1 data as the null phenotype.
The common variants in the genotyping data were
used to estimate the genetic similarity matrix. As for the
sequencing data, we selected only the nonsynonymous
mutations for the association test in recognition of the
fact that variants causing amino acid alterations tend to
have large effects on the phenotype.
The model
We used the following linear mixed model to adjust for
familial relatedness: Y = Cγ + Xβ + Zα + e where Y repre-
sents the phenotype (quantitative trait), C represents the
collection of the covariates (age and gender), X includes
the genotypes of the variants to be tested, and Z is the
design matrix for the whole-genome polygenic random
effects α. Finally, γ and β are fixed effects and e is the ran-
dom residual. When the random effects are integrated out,
the model is marginalized as Y ∼ N(Cγ + Xβ ,Kσ 2α + Iσ 2e ),
where σ 2α and σ
2

are the variances for the random
effects α and e, respectively. As for K, one could use twice
the theoretical kinship matrix to represent the familial
relationships. However, to account for potential cryptic
relatedness between individuals across different
families, we used a genetic similarity matrix that was






(zim − 2fm)(zjm − 2fm)
2fm(1 − fm) ,
where zim is the num-
ber of minor alleles for ith individual at the mth marker,
fm is the allele frequency for the mth marker, and p is the
total number of markers in the genotyping data.
We investigated 4 methods of association analysis: (a) a
single-variant association test without adjusting for familial
relatedness (UNI), that is, the component Zα is excluded
in the model; (b) a single-variant association test adjusting
for familial relatedness (UNI-ADJ); (c) a kernel score test
without adjusting for familial relatedness (SKAT); and (d)
a kernel score test adjusting for familial relatedness
(SKAT-ADJ). The first method is a simple linear regres-
sion. The second method tests the null hypothesis of zero
fixed effects in a linear mixed model. Specifically, we used
the likelihood ratio test implemented in the software
GEMMA [6]. The third method is the direct application of
the SKAT software [3] that ignores familial relatedness. As
for the fourth method, we adopted the approach described
in Ref. [7]. Specifically, we estimated the covariance matrix
R = cov (Zα + e) = Kσ 2α + Iσ
2
e under the null model with-
out genes or variants being tested. Then we applied a data
transformation to calculate Y˜ , X˜, and C˜, where:
X˜ = R−1/2X, X˜ = R−1/2X, C˜ = R−1/2C, leading to the fol-
lowing transformed model, Y˜ = C˜γ + X˜β + e˜, where
e˜ = R−1/2(Zα + e). Note that each e˜i is independent and
identically distributed; therefore, the kernel score test can
be appropriately applied on the transformed data.
Results
Simulated data
For the simulated data, we analyzed the genes that
explain the highest percentages of SBP variance (the per-
centages of SBP variance explained by each gene in the
simulation were provided by the GAW18 organizers)
using the 4 methods described above. Genes without
nonsynonymous mutations were excluded. For the first
two single-variant methods, we performed a Bonferroni
correction on the smallest p value of the variants in a
gene to obtain the gene-level p value. To assess the false-
positive rate, we also calculated the p values using Q1 as
the phenotype. The power and the false-positive rate
were calculated based on the 200 replicates. Table 1
shows the results for the top 7 genes. As the table shows,
ignoring familial relatedness results in inflation of the
false-positive rate using the UNI and SKAT methods, in
contrast with the UNI-ADJ and SKAT-ADJ methods,
which still demonstrate good control of the false-positive
rate. As for the power, the single-variant method does
better for genes whose effects on the phenotype are
dominated by a single variant (eg, LEPR) whereas the col-
lapsing method is more powerful for genes containing
multiple variants with comparable effect sizes.
Real data
Consistent with our observation in the simulated data, the
Q-Q plot (Figure 1) shows that the UNI and SKAT meth-
ods that ignore familial relatedness result in substantial
inflation of the false-positive rate. For UNI-ADJ, only 1
variant (chr11:119059358) has a Bonferroni-corrected
p value smaller than 0.05 (PBonferroni = 0.038). It is a coding
variant for gene PDZD3. To our knowledge, the literature
has suggested no role for this gene in blood pressure. For
SKAT-ADJ, there is no gene with a Bonferroni-corrected
p value smaller than 1.
Discussion and conclusions
In this study, we investigated the utility of linear mixed
models in adjusting for familial structure. We also
attempted to combine a linear mixed model method
with a kernel score test–a state-of-the-art collapsing
methodology that tests for association between a group
of variants and a phenotype.
Conclusions
We found that linear mixed models are able to satisfac-
torily adjust for familial relatedness in the sense that
false-positive rates are well controlled at the nominal
significance level. Not surprisingly, in terms of the sta-
tistical power, the performance of the single-variant
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method and the collapsing method depends on the dis-
tribution of the variants’ effect sizes within the gene.
The single-variant method is more powerful for genes
with one dominating causal variant, whereas the collap-
sing method is more powerful for genes with multiple
causal variants of similar effect sizes.
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